Clinical Trial Update: Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of eculizumab to prevent antibody-mediated rejection in sensitized kidney transplant recipients from decea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplant Recipient

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Stage V Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-05-03